Rank #1: Hypoglycemia and Hyperglycemia: Recognition and Treatment
Host: Shira Johnson, MD
Diagnosing and treating high and low blood glucose levels is not always straightforward. Dr. Rita Cydulka, professor and vice-chair of the department of emergency medicine at Case Western Reserve University, discusses case management issues, including unusual presentations of abnormal blood sugars. In her interview with host Dr. Shira Johnson, Dr. Cydulka highlights the initial approach as well as clinical caveats for discharge and follow-up.
Nov 06 2008
Rank #2: Do We Already Have the Cure for Type 1 Diabetes?
Host: Bruce Bloom, DDS, JD
We spend billions each year to research possible cures for type I diabetes, but the cure may already be on the shelf. Join host Dr. Bruce Bloom and his guest, Dr. Denise L. Faustman, associated professor of medicine at Harvard Medical School and director of the Immunobiology Laboratories at Massachusetts General Hospital, as they explore the first clinical trial using generic drugs to try to cure type I diabetes.
Nov 05 2008
Rank #3: Hot Topics in Diabetes: What Endocrinologists are Talking About
Dr. Brian McDonough welcomes Dr. Tina Thethi, Assistant Professor of Medicine in the section of Endocrinology and Metabolism at Tulane University Health Sciences Center. Dr. Thethi provides the inside scoop on diabetes topics of particular interest to endocrinologists in practice today, from pre-diabetes management to continuous glucose monitoring to novel drug research and development.
Jul 27 2015
Rank #4: Diabetes Research Suggests Better Long Term Outcomes with Early Insulin
Host Jennifer Caudel, DO welcomes Jay Shubrook, DO, Director of Clinical Research and Diabetes Services at Touro University-California College of Osteopathic Medicine. Recorded on site at the American Osteopathic Association's annual medical education conference, Dr. Shubrook discusses a pilot study in which newly diagnosed type 2 diabetes patients were treated with early insulin rather than lifestyle changes and oral therapies alone. The results suggested not only good safety profiles, but also better long-term outcomes for patients.
Nov 30 2015
Rank #5: Clinical Limitations of the Metabolic Syndrome: Do We Need to Redefine the Concept?
Host: Maurice Pickard, MD
Metabolic syndrome is generally considered to be a combination of conditions that increases a patient's risk of developing coronary artery disease. These conditions include elevated blood pressure, obesity, insulin resistance, elevated C-reactive proteins and high triglycerides or HDL cholesterol. If a patient has three or more of these conditions, he or she is classified as having metabolic syndrome. But what is the clinical applicability of this "syndrome," and should practicing physicians still be using the metabolic syndrome concept? Dr. Gerald Reaven, active emeritus professor of medicine at the Stanford University School of Medicine in Stanford, California, suggests that there are more reliable methods than the metabolic syndrome classification for determining a patient's risk of developing coronary artery disease. Dr. Maurice Pickard hosts.
Oct 18 2010
Rank #6: The Role of the Certified Diabetes Educator: A Team Effort
Guest: Candis Morello, PharmD, CDE
Candis M Morello, Professor of Clinical Pharmacy at UC San Diego Skaggs School of Pharmacy and Pharmaceutical Sciences, joins Dr. John Russell to talk about team-based care integrations of certified diabetes educators to help empower diabetes patients and improve long-term outcomes.
Diabetes Discourse, a non-certified educational series, is brought to you by AstraZeneca, pushing the boundaries of science to create life-changing medicines for people with diabetes. Content of this diabetes education is produced and solely controlled by ReachMD. This series is intended for healthcare professionals only.
Brought to you by
Aug 31 2015
Rank #7: Regeneration of Insulin-Producing Islets in our Patients
Host: Bruce Bloom, DDS, JD
Researchers are looking at hundreds of ways to treat and cure type one diabetes. Most of the advances so far have come in newly diagnosed children. Is there anything on the horizon to help adults with established type one diabetes? Dr. Alexander (Zan) Fleming, chairman and chief medical officer of Exsulin, joins host Dr. Bruce Bloom to discuss the new therapies for reversing established diabetes.
Nov 02 2010
Rank #8: The Hygiene Hypothesis and Risk of Type 1 Diabetes in Children
Host: Mary Leuchars, MD
Improved living conditions and hygiene may be contributing to the rise of type 1 diabetes in children, but does the "hygiene hypothesis" fully explain the onset of type 1 diabetes in this population? What factors might explain the increased incidence of type 1 diabetes among pediatric patients in the US, Sweden and Finland, in particular? Dr. Carolyn Paris, pediatrician and emergency medicine specialist at the Center for Clinical and Translational Research at Seattle Children's Hospital, explores the indirect evidence that examines environmental influences in the development of type 1 diabetes in children. Dr. Mary Leuchars hosts.
Oct 28 2010
Rank #9: Recommending Physical Activity for Your Diabetes Patients
Host: Jennifer Shu, MD
In the state of Texas, patients can buy home exercise equipment without sales tax if they present a medical script written by their healthcare provider, at the time of purchase. Is this benefit available in your state? Host Dr. Jennifer Shu welcomes Dr. Jill Grimes, a practicing board-certified family physician in Austin, Texas, and an associate editor of the 5-Minute Clinical Consult textbook, to explore key strategies to get your patients with diabetes to do their best to keep fit. Exercise as a daily commitment is a tough proposition for many of our patients, with work, family, and other activities all competing for their time. Many patients also battle a kind of personal inertia about exercise, just as others perceive constraints imposed by chronic diseases like diabetes. How can you tailor your discussions about exercise to resonate with your patients?
Nov 05 2008
Rank #10: The Highs and Lows of Managing Diabetes in Teenagers
Host: Mary Leuchars, MD
For teenage diabetic populations, maintaining good glycemic control is often a low priority. Clinicians and families need to be aware of special considerations in this age group to ensure better control and reduce risk for postpubertal complication. How do physicians optimize management protocols for patients entering a stage of rapid hormonal flux? Can school support systems and peer groups play integral roles? Answering these questions with host Dr. Mary Leuchars is Dr. H. Peter Chase, professor of pediatrics at the University of Colorado Health Sciences Center and past executive and clinical director of the Barbara Davis Center for Childhood Diabetes in Denver, Colorado.
Nov 03 2008
Rank #11: The Cost of Diabetes to the Healthcare System
Host: Bruce Japsen
The new health reform law will take steps to encourage patients to use preventive tests and screenings to head off chronic conditions, like diabetes, that extract a huge toll on the nation's medical care budget. Exactly how much does diabetes care cost the medical system, and where is the money going? Dr. Joanna Jiang, senior research scientist at the AHRQ (the Agency for Healthcare Research and Quality), tells host Bruce Japsen about the origin of hospital costs and its surprising toll on the system.
Oct 20 2010
Rank #12: The Rising Diabulimia Epidemic: Safeguarding Diabetic Patients with Eating Disorders
Diabulimia, defined as the manipulation of insulin treatments by Type 1 diabetic patients in order to lose weight, is a rising problem among teens and young adults in the U.S, particularly young women. Joining Dr. Brian McDonough to discuss this dual diagnosis phenomenon of diabetes and eating disorders, ways in which they exacerbate other disease processes, the long term consequences, and management priorities for phycisians is author and registered dietitian Susan Weiner. Susan is a recipient of the AADE Diabetes Educator of the Year award and has devoted much of her writing and clinical expertise to addressing diabulimia in at-risk patients.
Dec 19 2016
Rank #13: Rates of Obesity and Diabetes Lower in More Walkable Neighborhoods
Despite targeted efforts to reduce obesity through diet and exercise, these rates continue to rise. A new study from Ontario, Canada found that obesity and diabetes rates were lower in more walkable neighborhoods compared to less walkable neighborhoods, where they saw an increase in these rates.
Researchers from St. Michael's Hospital in Toronto studied almost 9,000 neighborhoods in Southern Ontario looking at walkability scores, along with government health data and survey results during a twelve-year period. They examined whether neighborhoods that were more walkable experienced a slower increase in obesity and diabetes compared to less walkable neighborhoods.
May 30 2016
Rank #14: Injectable Medication as an Alternative Treatment for Diabetic Eye Disease
Proliferative diabetic retinopathy (PDR) is a leading cause of vision loss in patients with diabetes, resulting in up to 24,000 cases of blindness each year in the United States. Laser therapy has been the most common treatment used to help reduce severe vision loss, but the procedure has many side effects including permanent loss of peripheral vision and swelling of the retina.
A group of researchers from across the US tested an alternative treatment using an injectable medication called ranibizumab, to see if it would be as effective as the laser therapy. They studied more than 300 patients with PDR, assigning them to either receive standard laser therapy or an injection into the eye. In total, they treated close to 400 eyes.
Outcomes, especially loss of vision, were compared at two years. Over the two year period, researchers found that patients receiving the injections of medication had fewer side effects and did somewhat better in terms of vision loss than those who received laser therapy.
Nov 25 2015
Rank #15: Clinical Trials to Cure Type 1 Diabetes With Generic Drugs
Host: Bruce Bloom, DDS, JD
The first clinical trial using generic drugs to cure type 1 diabetes has created quite a buzz in the diabetic patient and physician communities. Join host Dr.Bruce Bloom and his guest, Dr. Denise L. Faustman, associate professor of medicine at Harvard Medical School and director of the Immunobiology Laboratories at Massachusetts General Hospital, as they discuss the details of this clinical trial and what the future holds.
Nov 05 2008